Liabilities / Assets
35th percentile
Higher debt load relative to assets than 35% of similar nonprofits.
990 • Fiscal year 2023 • EIN 20-1896813
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
35th percentile
Higher debt load relative to assets than 35% of similar nonprofits.
Liabilities / Revenue
40th percentile
Higher debt load relative to revenue than 40% of similar nonprofits.
Net Margin
67th percentile
Higher net margin than 67% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
59th percentile
Faster asset growth than 59% of similar nonprofits.
Revenue Growth
68th percentile
Faster revenue growth than 68% of similar nonprofits.
Assets
Up$8,268,932
Up $656,421 (+8.6%) from 2022
Net Assets
Up$7,836,800
Up $481,824 (+6.6%) from 2022
Liabilities
Up$432,132
Up $174,597 (+68%) from 2022
Revenue
Up$3,706,775
Up $558,436 (+18%) from 2022
Expenses
Up$3,249,439
Up $118,280 (+3.8%) from 2022
Net Income
Up$457,336
Up $440,156 (+2562%) from 2022
This 2023 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
To be the preeminent source of medical-grade porcine tissue utilized to cure diseases, with the primary commitment to diabetes.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2023 • Form 990Summary only. Only limited summary data is available for this year.